期刊文献+

乳腺癌前哨淋巴结手术中分子评估分析 被引量:2

Analysis of intraoperative molecular assessment of sentinel lymph nodes in breast carcinoma
原文传递
导出
摘要 【目的】评价GeneSearchTM乳腺淋巴结检测技术(简称Genesearch)在乳腺癌前哨淋巴结(SLN)转移评估中的可靠性及应用前景。【方法】对2010年5—8月北京大学第一医院、北京人民医院及卫生部北京医院共80例乳腺癌患者的140枚SLN,采用Genesearch法检测细胞角蛋白19和乳腺球蛋白的表达水平并对照冰冻和石蜡组织学结果进行评估。其中女性78例,男性2例,年龄29~85岁,中位年龄49岁。【结果】全部140枚SLN中,组织学诊断无肿瘤转移121枚,宏转移17枚,微转移2枚,未见孤立肿瘤细胞。Genesearch检测结果阴性119枚,阳性21枚,灵敏度为89.4%,特异度为96.7%,阳性预测值为81.0%(17/21),阴性预测值为98.3%(117/119),与组织学诊断的总符合率为95.7%。其中对宏转移的检测灵敏度为15/17,对微转移的检测灵敏度为2/2。【结论】Genesearch检测具有较高的灵敏度和特异度;技术操作应严格,避免假阳性和假阴性;对阳性结果不能分类可能是阻碍其广泛应用的关键。 Objective To evaluate the reliability and application of GeneSearchTM breast lymph node assay (Genesearch), a real-time fluorescence quatitative PCR method, in intraoperative assay of metastasis in sentinel lymph nodes (SLNs) from breast cancer patients. Methods Totally 140 SLNs from 80 patients with breast carcinoma were prospectively studied from May 2010 to August 2010. The 80 patients included 78 women and 2 men who ranged in age from 29 to 85 years, and the median age is 49 years. The expression of CK19 and mammaglobulin in all 140 SLNs were detected by Genesearch, and the results were compared with that of histological evaluation of both frozen and paraffin-embedded sections. Results Among SLNs, by histological analyses, there were 121 without metastasis, 17 with macrometastasis, 2 with micrometastasis, and none of isolated tumor cell. By Geneseareh, there were 119 without metastasis and 21 with metastasis. Genesearch showed sensitivity of 89. 4%, positive predictive value of 81.0%, negative predictive value of 98.3% and specificity of 96. 7% by comparing to histological analyses. The concordance between Genesearch and histological analysis was 95.7%. The sensitivity of Genesearch was 15/17 for macrometastasis and 2/2 for micrometastasis. Conclusions Genesearch detection presents high sensitivity and specificity in evaluating metastasis of sentinel lymph nodes in breast cancer, but strict performance technically is necessary to avoid false positive and false negative results. Inability of further subtyping for the positive cases might be the key limitations for wide application of this method.
出处 《中华外科杂志》 CAS CSCD 北大核心 2013年第2期135-138,共4页 Chinese Journal of Surgery
基金 北京市科技计划项目基金资助(D09050703570905) 首都医学发展科研基金(2009-1011)
关键词 乳腺癌 前哨淋巴结 分子诊断 Breast cancer Sentinel lymph node Molecular diagnosis
  • 相关文献

参考文献13

  • 1Lyman GH,Giuliano AE,Somerfield MR. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].Journal of Clinical Oncology,2005,(30):7703-7720.doi:10.1200/JCO.2005.08.001.
  • 2Layfield DM,Agrawal A,Roche H. Intraoperative assessment of sentinel lymph nodes in breast cancer[J].British Journal of Surgery,2011.4-17.
  • 3Blumencranz P,Whitworth PW,Deck K. Scientific Impact Recognition Award.Sentinel node staging for breast cancer:intraoperative molecular pathology overcomes conventional histologic sampling errors[J].American Journal of Surgery,2007.426-432.
  • 4Mansel RE,Goyal A,Douglas-Jones A. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room:results of the Cardiff study[J].Breast Cancer Research and Treatment,2009.595-600.
  • 5Tafe LJ,Schwab MC,Lefferts JA. A validation study of a new molecular diagnostic assay:the Dartmouth-Hitchcock Medical Centre experience with the GeneSearch BLN assay in breast sentinel lymph nodes[J].Experimental and Molecular Pathology,2010.1-6.
  • 6Singletary SE,Allred C,Ashley P. Revision of the American Joint Committee on Cancer staging system for breast cancer[J].Journal of Clinical Oncology,2002.3628-3636.
  • 7Krag DN,Anderson S J,Julian TB. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer:results from the NSABP B-32 randomized phase Ⅲ trial[J].Lancet Oncology,2007.881-888.
  • 8Backus J,Laughlin T,Wang Y. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis[J].Journal of Molecular Diagnostics,2005.327-336.
  • 9Martin Martinez MD,Veys I,Majjaj S. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes[J].European Journal of Surgical Oncology,2009.387-392.
  • 10Julian TB,Blumencranz P,Deck K. Novel intraoperative molecular test for sentinel lymph node metastasis in patients with early-stage breast cancer[J].Journal of Clinical Oncology,2008.3338-3345.

同被引文献21

  • 1Fan L, Strasser-Weippl K, Li J, et al. Breast cancer in China [J]. Lancet Oncol, 2014, 15(7) : e279 -e289.
  • 2Zhao YP. Interpretation of the Chinese Edition of NCCN Clinical Practice Guidelines in Oncology-Panceatic Adenocarcinoma Guideline 2011 [ J]. Zhonghua Wai Ke Za Zhi(Chin J Surg), 2011,49(9) : 771 -773.
  • 3Roberts CA, Beitsch PD, Litz CE, et al. Interpretive dispari- ty among pathologists in breast sentinel lymph node evaluation [J]. Am J Surg, 2003, 186(4) : 324 -329.
  • 4Layfield DM, Agrawal A, Roche H, et al. Intraoperative assess- ment of sentinel lymph nodes in breast eancer [ J]. Br J Surg, 2011 ,98(1):4-17.
  • 5Blumencranz P, Whitworth PW, Deck K, et al. Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraop- erative molecular pathology overcomes conventional histologie sam-piing errors[J]. Am J Surg, 2007, 194(4) : 426 -432.
  • 6Hughes SJ, Xi L, Raja S, et al. A rapid, fully automated, mo- lecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer[J]. Ann Surg, 2006, 243(3) : 389 -398.
  • 7Tsujimoto M, Nakabayasbi K, Yoshidome K, et al. One-step nu- cleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients[ J]. Clin Cancer Res, 2007, 13(16) : 4807 -4816.
  • 8Hao X, Liu Y, Li X, et al. An intra-operative RT-LAMP method allows rapid and reliable detection of sentinel lymph node metas- tasis in breast cancer patients [ J]. Virehows Arch, 2015, 466 (2) : 169 -176.
  • 9Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time re- verse-transcription-polymerase chain reaction assay for mammaglo- bin and cytokeratin 19 on axillary sentinel lymph nodes of breast car- cinoma patients[J]. Ann Surg, 2008, 247(1): 136 -142.
  • 10Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer [ J ]. J Clin Oncol, 2008, 26 (20) : 3338 - 3345.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部